Trump’s Crackdown on Federal Regulations

The President has signed an executive order requiring that federal agencies, including the FDA, to cut two regulations for every new one they adopt.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, STAFF OF POTUSPresident Donald Trump signed an executive order on Monday (January 30) that will require federal agencies to repeal two existing regulations for every new one they adopt. “It is the policy of the executive branch to be prudent and financially responsible in the expenditure of funds,” according to the executive order. “It is essential to manage the costs associated with the governmental imposition of private expenditures required to comply with Federal regulations.”

As he signed the order, STAT News reported, Trump said he was fulfilling a campaign promise to loosen government regulations and promote innovation. “There will be regulation, there will be control,” he said. “But it will be normalized control.”

Rick Pollack, CEO of the American Hospital Association, praised the executive order in a statement. “Reducing the administrative complexity of health care would allow providers to spend more time on patients, not paperwork,” he wrote. “Excessive red tape not only stands as a barrier to care but as a key driver of cost.”

But some officials were less certain that the executive order was a good idea. As STAT reported, the order could cripple the 21st Century Cures Act, the landmark legislation passed to accelerate US ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Joshua A. Krisch

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo